EXW
Depend on quantity
PRODUCT NAME: ELASTY
SUBTITLE: Cross-linked Hyaluronic Acid / Higher Safety, Advanced Monophasic
BRAND OVERVIEW
•ELASTY™ is an advanced, high-safety monophasic cross-linked hyaluronic acid dermal filler designed for restoring volume, defining contours, and enhancing aesthetic results.
•Engineered with patented PNET™ (Preserved Natural Entanglement Technology), ELASTY™ maximizes cross-linking efficiency with a minimal degree of modification (MoD), ensuring a high level of biocompatibility, exceptional elasticity, and natural-looking volume retention.
CORE STRENGTH
•PNET™ (Preserved Natural Entanglement Technology): Preserves the natural cross-linked and entangled HA network while introducing minimal synthetic cross-links to achieve superior stability and long duration.
•Low Degree of Modification (MoD): Minimizes structural deviation from natural hyaluronic acid, delivering high biocompatibility, reducing delayed side effects, and enabling easy reversal with hyaluronidase if correction is required.
•High Resistance to Deformation (G) & Shear Viscosity:* Exhibits high elastic modulus and cohesive force to lift skin tissue effectively and maintain the desired volume shape over time.
•Dual Cleaning Process: Eliminates uncross-linked and open-cross-linked BDDE through a rigorous two-step purification process.
SAFETY PROFILE & QUALITY CONTROL
•Ultra-Low BDDE Level: Features minimal residual BDDE levels (< 0.2 ppm) to ensure safety and prevent adverse reactions.
•Undetectable Endotoxin Levels: Processed under strict quality criteria (< 0.005 EU/ml actual experimental results) to significantly reduce inflammatory responses.
•Manufactured with Water For Injection (WFI): Formulated using medical-grade Water For Injection rather than standard purified water to prevent side effects and microbial contamination.
•CE Certified Quality Assurance: Certified under European Medical Device regulations (CE Certificate 2195-MED-1834101) with full quality assurance systems.
•Clinically Evaluated Efficacy: Clinically validated via WSRS (Wrinkle Severity Rating Scale) and GAIS (Global Aesthetic Improvement Scale) evaluations, demonstrating long duration and comparable volumetric performance against major premium market references.
PRODUCT TYPES & SPECIFICATIONS
1. ELASTY G (Grand / Volume)
•Gel Type: Monophasic cross-linked HA
•HA Concentration: 24 mg/mL
•Injection Force: 10–20 N
•Residual BDDE Level: < 0.2 ppm
•Packaging & Contents: 1.0 mL x 2 pre-filled syringes
•Needle Specification: 27G Ultra Thin Wall (UTW), 2 EA
•Indications & Usage: Deep volumizing and structural contouring. Designed for deep injection into dorsal skin, malar/submalar augmentation, and severe facial volume restoration with high resistance to deformation.
2. ELASTY D (Deep)
•Gel Type: Monophasic cross-linked HA
•HA Concentration: 24 mg/mL
•Injection Force: 10–20 N
•Residual BDDE Level: < 0.2 ppm
•Packaging & Contents: 1.0 mL x 2 pre-filled syringes
•Needle Specification: 27G Ultra Thin Wall (UTW), 2 EA
•Indications & Usage: Mid-to-deep dermal fold correction and facial shaping. Ideal for correcting severe facial wrinkles, nasolabial folds, and restoring lost mid-face volume.
3. ELASTY F (Fine)
•Gel Type: Monophasic cross-linked HA
•HA Concentration: 24 mg/mL
•Injection Force: 10–20 N
•Residual BDDE Level: < 0.2 ppm
•Packaging & Contents: 1.0 mL x 2 pre-filled syringes
•Needle Specification: 27G Ultra Thin Wall (UTW), 2 EA
•Indications & Usage: Superficial-to-mid dermis smoothing and subtle refinement. Suitable for correcting light-to-moderate wrinkles, fine lines, and delicate skin areas requiring soft, smooth elasticity.
TREATMENT AREAS & INDICATIONS
•Forehead Folds & Lines
•Temples & Mid-Face Area
•Cheek & Malar Augmentation
•Nasolabial Folds (Smile Lines)
•Chin Augmentation & Jawline Definition
•Deep Facial Contour Deficits
The person in charge
JONGRYUL PARKAddress
31 Digital-ro 30-gil, Guro-gu, Seoul (08390)Please enter the text on the left image to prevent automatic input.
0 / 4000